We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Genealogy Testing Service Relies on High-Throughput Microarray Technology

By LabMedica International staff writers
Posted on 19 May 2010
An advanced genotyping system is the basis for a new genealogic testing service that can match a wide range of family relationships within five generations. More...


Family Tree DNA (Houston, TX, USA), the first company to develop the commercial application of DNA testing for genealogical purposes, has launched a new genotyping service (The Family Finder) that will allow individuals, regardless of gender, to explore linkages to grandparents, aunts and uncles, half siblings, and first, second, third, and fourth cousins.

The test is based on Affymetrix (Santa Clara, CA, USA) Axiom genotyping technology and the associated GeneTitan analytical system. With the Axiom test, total genomic DNA (200 ng) is amplified and randomly fragmented into 25-125 base pair fragments. These fragments are purified, resuspended, and hybridized to Axiom Genome-wide human array plates. Following hybridization, the bound target is washed under stringent conditions to remove nonspecific background to minimize background noise caused by random ligation events. Each polymorphic nucleotide is queried via a multicolor ligation event carried out on the array surface. After ligation, the arrays are stained and imaged on the GeneTitan Instrument. The imaging device in the GeneTitan Instrument uses an external, high-intensity xenon lamp and dual excitation and emission filters to capture images from array plates.

The Family Finder test analyzes the DNA of two individuals using Axiom array plates containing nearly 570,000 genetic markers, including many that are relevant to genealogy. The assay system utilizes the complete Axiom genotyping solution, which includes array plates, complete reagent kits, and an automated workflow that enables scientists to process more than 760 samples per week. Family Tree DNA then analyzes the resulting data with internally developed algorithms to determine the closeness of the relationship.

"This is the most exciting genetic genealogy breakthrough since 2000, when Family Tree DNA launched its Y-DNA test to uncover relatives in the direct paternal line,” said Bennett Greenspan, CEO of Family Tree DNA. "The comprehensive, genome-wide coverage of Axiom Arrays enables us to offer consumers the most advanced genealogical test available at a price that is attractive to our customers. In addition, the automated GeneTitan system allows us to process hundreds of samples at a time with minimal hands-on time for maximum efficiency.”

"The Family Finder test represents a huge step forward for the direct-to-consumer genetic genealogy market and the application of microarray technology,” said Kevin King, CEO of Affymetrix. "Now anyone can utilize the power of the Axiom genotyping solution and the GeneTitan System to find and connect with a broader range of family members than ever before.”

Related Links:

Family Tree DNA
Affymetrix



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.